Chlorthalidone for Resistant Hypertension in Advanced Chronic Kidney Disease.
作者信息
Agarwal Rajiv, Sinha Arjun D, Tu Wanzhu
机构信息
Division of Nephrology, Department of Medicine (R.A., A.D.S.), Indiana University School of Medicine, Indianapolis.
Richard L. Roudebush Veterans Administration Medical Center, Indianapolis, IN (R.A., A.D.S.).
出版信息
Circulation. 2022 Aug 30;146(9):718-720. doi: 10.1161/CIRCULATIONAHA.122.060167. Epub 2022 Aug 29.
Abstract
摘要
相似文献
1
Chlorthalidone for Resistant Hypertension in Advanced Chronic Kidney Disease.氯噻酮用于晚期慢性肾脏病的顽固性高血压治疗
Circulation. 2022 Aug 30;146(9):718-720. doi: 10.1161/CIRCULATIONAHA.122.060167. Epub 2022 Aug 29.
2
Chlorthalidone for Hypertension in Advanced CKD. Reply.氯噻酮用于晚期慢性肾脏病高血压的治疗。回复
N Engl J Med. 2022 Apr 7;386(14):1384. doi: 10.1056/NEJMc2201160.
3
Mechanisms of Antihypertensive Effect of Chlorthalidone in Advanced Chronic Kidney Disease: A Causal Mediation Analysis.氯噻酮在晚期慢性肾脏病中降压作用的机制：因果中介分析。
Clin J Am Soc Nephrol. 2024 Aug 1;19(8):1025-1032. doi: 10.2215/CJN.0000000000000484. Epub 2024 Jun 12.
4
The thiazide-like diuretic chlorthalidone as an alternative evidence-based therapy for resistant hypertension in patients with stage 4 chronic kidney disease.噻嗪类利尿剂氯噻酮作为4期慢性肾病患者顽固性高血压的一种循证替代疗法。
Expert Rev Clin Pharmacol. 2024 May-Jun;17(5-6):415-418. doi: 10.1080/17512433.2024.2333776. Epub 2024 Mar 22.
5
Chlorthalidone for Hypertension in Advanced CKD.氯噻酮用于晚期慢性肾脏病患者的高血压治疗
N Engl J Med. 2022 Apr 7;386(14):1383-1384. doi: 10.1056/NEJMc2201160.
6
Chlorthalidone for Hypertension in Advanced CKD.氯噻酮用于晚期慢性肾脏病高血压的治疗
N Engl J Med. 2022 Apr 7;386(14):1382-1383. doi: 10.1056/NEJMc2201160.
7
Chlorthalidone for Hypertension in Advanced CKD.氯噻酮用于晚期慢性肾脏病患者的高血压治疗
N Engl J Med. 2022 Apr 7;386(14):1382. doi: 10.1056/NEJMc2201160.
8
Chlorthalidone and Advanced Chronic Kidney Disease.氯噻酮与晚期慢性肾脏病
Clin J Am Soc Nephrol. 2022 Jul;17(7):1076-1078. doi: 10.2215/CJN.01380222. Epub 2022 May 16.
9
Chlorthalidone in advanced CKD.氯噻酮用于晚期慢性肾脏病
Nat Rev Nephrol. 2022 Jan;18(1):3. doi: 10.1038/s41581-021-00514-3.
10
Chlorthalidone in Advanced Chronic Kidney Disease - Have We Missed a Trick?氯噻酮用于晚期慢性肾脏病——我们错失了一个窍门吗？
N Engl J Med. 2021 Dec 30;385(27):2574-2575. doi: 10.1056/NEJMe2118149.
引用本文的文献
1
Efficacy and Safety of Aldosterone Synthase Inhibitors for Resistant Hypertension: A Systematic Review and Meta-Analysis.醛固酮合酶抑制剂治疗顽固性高血压的疗效与安全性：一项系统评价和荟萃分析
Rev Cardiovasc Med. 2025 Aug 19;26(8):39555. doi: 10.31083/RCM39555. eCollection 2025 Aug.
2
Optimizing Nephron Performance: The Old, the New, and the New-Old Diuretic Therapies.优化肾单位功能：传统、新型及新旧结合的利尿疗法
Biomedicines. 2025 Jun 9;13(6):1413. doi: 10.3390/biomedicines13061413.
3
Balancing Stone Prevention and Kidney Function: A Therapeutic Dilemma.平衡结石预防与肾功能：一个治疗困境
J Clin Med. 2025 May 23;14(11):3678. doi: 10.3390/jcm14113678.
4
A Pragmatic Approach to Acute Cardiorenal Syndrome: Diagnostic Strategies and Targeted Therapies to Overcome Diuretic Resistance.急性心肾综合征的实用方法：克服利尿剂抵抗的诊断策略和靶向治疗
J Clin Med. 2025 Apr 26;14(9):2996. doi: 10.3390/jcm14092996.
5
Diuretics in patients with chronic kidney disease.慢性肾脏病患者的利尿剂
Nat Rev Nephrol. 2025 Apr;21(4):264-278. doi: 10.1038/s41581-024-00918-x. Epub 2025 Jan 7.
6
New trials in resistant hypertension: mixed blessing stories.顽固性高血压的新试验：喜忧参半的故事。
Clin Kidney J. 2023 Sep 27;17(1):sfad251. doi: 10.1093/ckj/sfad251. eCollection 2024 Jan.
7
Hypertension in chronic kidney disease-treatment standard 2023.慢性肾脏病高血压治疗标准 2023.
Nephrol Dial Transplant. 2023 Nov 30;38(12):2694-2703. doi: 10.1093/ndt/gfad118.
8
Should we CLICK on chlorthalidone for treatment-resistant hypertension in chronic kidney disease?对于慢性肾脏病中难治性高血压，我们应该选择氯噻酮进行治疗吗？
Clin Kidney J. 2022 Dec 20;16(5):793-796. doi: 10.1093/ckj/sfac272. eCollection 2023 May.
9
Thiazides in chronic kidney disease: "back to the future".噻嗪类药物在慢性肾脏病中的应用：“回归未来”
Clin Kidney J. 2022 Oct 18;16(1):1-4. doi: 10.1093/ckj/sfac228. eCollection 2023 Jan.
本文引用的文献
1
Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease.氯沙坦治疗晚期慢性肾脏病的高血压。
N Engl J Med. 2021 Dec 30;385(27):2507-2519. doi: 10.1056/NEJMoa2110730. Epub 2021 Nov 5.
2
Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial.聚磺苯乙烯钠（patiromer）对比安慰剂，以增加耐治疗高血压合并慢性肾脏病（CKD）患者使用螺内酯的可能性（AMBER）：一项 2 期、随机、双盲、安慰剂对照试验。
Lancet. 2019 Oct 26;394(10208):1540-1550. doi: 10.1016/S0140-6736(19)32135-X. Epub 2019 Sep 15.
3
Aldosterone antagonists for preventing the progression of chronic kidney disease.用于预防慢性肾脏病进展的醛固酮拮抗剂。
Cochrane Database Syst Rev. 2014 Apr 29(4):CD007004. doi: 10.1002/14651858.CD007004.pub3.
4
Prevalence and prognostic role of resistant hypertension in chronic kidney disease patients.慢性肾脏病患者中耐药性高血压的流行情况及其预后作用。
J Am Coll Cardiol. 2013 Jun 18;61(24):2461-2467. doi: 10.1016/j.jacc.2012.12.061. Epub 2013 Apr 23.
5
Efficacy of low-dose spironolactone in subjects with resistant hypertension.低剂量螺内酯对顽固性高血压患者的疗效。
Am J Hypertens. 2003 Nov;16(11 Pt 1):925-30. doi: 10.1016/s0895-7061(03)01032-x.
Zotero 插件